Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Doximity Inc (NYSE: DOCS) closed the day trading at $59.31 up 1.59% from the previous closing price of $58.38. In other words, the price has increased by $1.59 from its previous closing price. On the day, 1.32 million shares were traded. DOCS stock price reached its highest trading level at $59.51 during the session, while it also had its lowest trading level at $57.71.
Ratios:
For a better understanding of DOCS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.76. For the most recent quarter (mrq), Quick Ratio is recorded 6.92 and its Current Ratio is at 6.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On February 07, 2025, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $31 to $78.
Leerink Partners Upgraded its Market Perform to Outperform on February 07, 2025, whereas the target price for the stock was revised from $60 to $90.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Wampler Kira Scherer sold 2,000 shares for $60.96 per share. The transaction valued at 121,920 led to the insider holds 16,618 shares of the business.
KIRA WAMPLER bought 2,000 shares of DOCS for $121,920 on Jul 01 ’25. On Jun 25 ’25, another insider, Benjamin Regina M., who serves as the Director of the company, sold 10,000 shares for $60.00 each. As a result, the insider received 600,000 and left with 16,618 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 11139959808 and an Enterprise Value of 10617988096. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 53.55, and their Forward P/E ratio for the next fiscal year is 37.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.53 while its Price-to-Book (P/B) ratio in mrq is 10.35. Its current Enterprise Value per Revenue stands at 18.615 whereas that against EBITDA is 45.06.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.37, which has changed by 1.1567273 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $25.00. The 50-Day Moving Average of the stock is 4.78%, while the 200-Day Moving Average is calculated to be 7.90%.
Shares Statistics:
Over the past 3-months, DOCS traded about 2.57M shares per day on average, while over the past 10 days, DOCS traded about 2065620 shares per day. A total of 137.78M shares are outstanding, with a floating share count of 132.76M. Insiders hold about 29.32% of the company’s shares, while institutions hold 67.48% stake in the company. Shares short for DOCS as of 1749772800 were 5590185 with a Short Ratio of 2.17, compared to 1747267200 on 9460960. Therefore, it implies a Short% of Shares Outstanding of 5590185 and a Short% of Float of 4.2.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
